Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JUNE 2021 Issue has been successfully launched on 1 June 2021.



Megha Vasani*, Rajendrakumar Mehta, Anandkumari Captain and Chandni Patel


Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases and is considered to be the main cause of cognitive impairment in elderly people. The major symptom of AD is progressive dementia that eventually results in dysfunction of daily life. Due to the fact that AD has a long period of incubation before clinical symptoms emerge, the available therapeutic treatments can only improve the symptoms but not delay the progression of AD. Age is the primary risk factor for Alzheimer’s disease. Alzheimer’s disease is a critical public health issue in many countries around the world, with a significant health, social, and financial burden on society. AD is a multifactorial disease, with no single cause known, and several modifiable and non-modifiable risk factors are associated with its development and progression. AD is caused by the accumulation of neurofibrillary proteins: beta-amyloid (Aβ) and hyperphosphorylated Tau in neurons. Overaccumulation of these aggregates leads to synaptic dysfunction and subsequent neuronal loss. This review totally discusses about the history, epidemiology, types, risk factors, pathophyisology, drugs and non-pharmacologic therapy.

Keywords: Alzheimer’s disease (AD), Dementia, Cholinesterase and neurodegenrative.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More